On Monday, 27 October 2025, Datavault AI announced a new software‑as‑a‑service agreement with Wellgistics Health to develop PharmacyChain, a blockchain‑enabled smart‑contract platform for prescription drug distribution. The partnership will leverage Datavault AI’s patented Information Data Exchange technology to create secure, token‑driven data scoring, valuation, and monetization for manufacturers, pharmacies, and insurers.
The agreement positions Wellgistics as a leading PBM‑agnostic alternative, enabling faster, smarter, and more affordable medication delivery. By integrating PharmacyChain, Wellgistics will be able to close the prescription loop, qualify pharmacies for optimized insurance reimbursement, and provide physicians with confirmation that patients receive their prescribed regimens.
Datavault AI’s CEO Nathaniel Bradley highlighted that the partnership will allow the company to expand its digital‑twin capabilities and generate new revenue streams within the $639 billion prescription drug market. The agreement includes a profit‑sharing license to be finalized later, marking a significant milestone in the company’s Web3 data monetization strategy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.